“…(4,5,16) The PDR phenotype was in accordance with the Kp196 resistome, which was composed of genes associated with resistance to aminoglycosides (aadA1, aacA4, strAB, aph(3')-VI, aac(3)-IId), fluoroquinolones (qnrS1, qnrB1, oqxAB), trimethoprim (dfrA14), sulfonamides (sul2), tetracycline (tetD), fosfomycin ( fosA5), chloramphenicol (catB3) and β-lactams including carbapenems (bla SHV-11 , bla CTX-M-15 , bla OXA-9 , bla OXA-1, bla TEM-1, bla NDM-1 ). Although less prevalent than the carbapenemase-coding bla KPC-2 gene, several studies demonstrated the occurrence of bla NDM-1 among clinical K. pneumoniae in Brazil, (17) including the ST11 lineage, where this gene was found in the context of an IncC plasmid. (18) Interestingly, the bla NDM-1 occurrence in Brazil was not restricted to clinical settings since it had already been found in environmental K. pneumoniae isolates recovered from both surface waters, (19) and wastewater treatment plants (WWTPs).…”